Lugano Financial Advisors SA (LFA)’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$58.3K Hold
310
0.03% 135
2025
Q4
$58.7K Hold
310
0.03% 143
2025
Q3
$51.4K Hold
310
0.03% 143
2025
Q2
$47.5K Hold
310
0.03% 141
2025
Q1
$48.8K Hold
310
0.03% 132
2024
Q4
$48.7K Hold
310
0.03% 147
2024
Q3
$55K Hold
310
0.04% 141
2024
Q2
$52.2K Hold
310
0.04% 136
2024
Q1
$51.6K Buy
+310
New +$51.3K 0.04% 128
2023
Q4
Sell
-385
Closed -$60K 177
2023
Q3
$60K Hold
385
0.05% 108
2023
Q2
$60.1K Buy
+385
New +$61.5K 0.04% 127
2023
Q1
Sell
-75
Closed -$12K 112
2022
Q4
$12K Hold
75
0.01% 110
2022
Q3
$11K Sell
75
-126
-63% -$19.1K 0.01% 106
2022
Q2
$29K Sell
201
-9,057
-98% -$1.35M 0.02% 101
2022
Q1
$1.5M Sell
9,258
-236
-2% -$38.2K 1% 29
2021
Q4
$1.8M Sell
9,494
-81
-0.8% -$15.6K 1.04% 30
2021
Q3
$1.94M Buy
9,575
+104
+1% +$21.8K 1.27% 26
2021
Q2
$1.91M Buy
9,471
+214
+2% +$39.8K 1.2% 26
2021
Q1
$1.62M Buy
9,257
+389
+4% +$70.3K 1.14% 25
2020
Q4
$1.5M Buy
8,868
+189
+2% +$31.1K 1.17% 25
2020
Q3
$1.39M Sell
8,679
-78
-0.9% -$12.7K 1.29% 23
2020
Q2
$1.44M Buy
+8,757
New +$1.33M 1.52% 20

Other funds holding BBH

Lugano Financial Advisors SA (LFA)'s BBH Position: Q1 2026 in Review

Lugano Financial Advisors SA (LFA) held its VanEck Biotech ETF (BBH) position steady in Q1 2026 at 310 shares worth $58.3K. The position accounts for 0.03% of the portfolio, ranked #135.

Lugano Financial Advisors SA (LFA) first reported a position in BBH in Q2 2020 and has held it in 22 quarters since. The position peaked at $1.94M in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Lugano Financial Advisors SA (LFA) held 310 shares of VanEck Biotech ETF worth $58.3K as of Q1 2026.
  • Lugano Financial Advisors SA (LFA) left its VanEck Biotech ETF share count unchanged in Q1 2026.
  • VanEck Biotech ETF made up 0.03% of Lugano Financial Advisors SA (LFA)'s portfolio in Q1 2026, its #135 holding.
  • Lugano Financial Advisors SA (LFA) first reported a position in VanEck Biotech ETF in Q2 2020 and has held it in 22 quarters since.
  • Lugano Financial Advisors SA (LFA)'s VanEck Biotech ETF position peaked at $1.94M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Lugano Financial Advisors SA (LFA)'s 13F filing for Q1 2026, filed 5 May 2026.